Search

Search Constraints

You searched for: Author/Creator Rubio, R

Search Results

1. Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. Issue 6 (9th January 2013)

3. Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir‐boosted protease inhibitor‐based versus a nonnucleoside reverse transcriptase inhibitor‐based first‐line regimen. Issue 9 (24th March 2014)

5. Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio. Issue 6 (11th December 2014)